Personalis (PSNL) Cash from Investing Activities (2018 - 2026)
Personalis (PSNL) posted quarterly Cash from Investing Activities of -$46.0 million for Q1 2026, down 104.12% year-over-year from $1.1 billion in Q1 2025, and down 219.99% quarter-over-quarter from -$14.4 million in Q4 2025.
Personalis (PSNL) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Personalis' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$46.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 104.12% year-over-year to -$46.0 million; the TTM figure through Mar 2026 stood at -$46.0 million (up 27.97% YoY), while the FY2025 annual figure was -$22.6 million, up 35.65% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$46.0 million, down from -$14.4 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $23.0 million in Q2 2022, with the low at -$46.0 million in Q1 2026.
- The 5-year median for Cash from Investing Activities is -$3.2 million (2022), against an average of -$2.2 million.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities surged 536.35% in 2023, then slumped 457.75% in 2025.
- Personalis' Cash from Investing Activities stood at $21.9 million in 2022, then sank by 153.26% to -$11.6 million in 2023, then tumbled by 124.98% to -$26.2 million in 2024, then jumped by 45.08% to -$14.4 million in 2025, then sank by 219.99% to -$46.0 million in 2026.
- Business Quant data shows PSNL's Cash from Investing Activities at -$46.0 million in Q1 2026, -$14.4 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Personalis | 1.40 Bn | 1.17 Bn | 281,000.00 | -46.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.01 Mn |
| Mar 31, 2026 | -46.01 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Jun 30, 2025 | -4.37 Mn |
| Jun 30, 2025 | -4.37 Mn |
| Mar 31, 2025 | -22.54 Mn |
| Mar 31, 2025 | -22.54 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Sep 30, 2024 | -28.18 Mn |
| Sep 30, 2024 | -28.18 Mn |
| Jun 30, 2024 | 12.99 Mn |
| Jun 30, 2024 | 12.99 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | -11.64 Mn |
| Dec 31, 2023 | -11.64 Mn |